Although we described that E2 can directly induce autocrine CCL2 in ER+ breast cancer, our data shown here suggest the modulatory effect of estrogen on tumor cells and normal endothelial cells cannot be due to the operation of CCL2 alone, and other secreted cytokines might also get involved in this process. This evidence concerns the gene ESR1 and breast cancer.